Qiagen Reports Grant of Restricted Stock Units to Board Member

2026-03-10 13:38:38

Abstract generation in progress

Qiagen has reported a managers’ transaction involving supervisory board member Bert van Meurs, who received 4,618 restricted stock units on February 27, 2026. This equity award is part of Qiagen’s share-based incentive programs, aiming to align leadership interests with long-term shareholder value and reflects standard governance practices for listed companies. The company, a life sciences and molecular diagnostics firm, currently has a “Buy” analyst rating with a $58.00 price target.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes